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Retroviral vectors derived from foamy or spumaretroviruses are considered promising tools for targeted gene delivery and vaccination
purposes. In order to fully exploit this potential, we identified essential cis-acting sequences on the feline foamy virus (FFV) genome by
constructing and analyzing a series of FFV-based replication-deficient vector genomes. Cis-acting sequences essentially required for marker gene
transfer were found to be localized at two sites on the FFV genome: (i) in the 5′-untranslated region and close to the gag ATG and (ii) in the central
part of the pol gene. The presence of two cis-acting sequences and their relative location on the FFV genome are similar but not identical to the
functionally corresponding elements described for simian and primate foamy viruses.
© 2006 Elsevier Inc. All rights reserved.Keywords: Spumavirus; Vector; Gene therapy; cis-acting element; PackagingIntroduction
Virus-mediated gene delivery by genetically engineered
vectors is an increasingly utilized technique in modern gene
therapy and vaccinology. Virus-based vector development
depends on an increased understanding of the biology and
replication strategy of the corresponding virus used, in
particular related to particle assembly, genome encapsidation,
maturation, and release from the virus/vector-producing cell
(Pfeifer and Verma, 2001).
For orthoretroviruses, comprising among others the murine
and avian leukemia and sarcoma viruses and the diverse
lentiviruses, the basic requirements for vector function have
been established over the past decades (Pfeifer and Verma,
2001): the main structural polyproteins Gag and Env and the
enzymatic activities comprising the Pol part of the Gag-Pol
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doi:10.1016/j.virol.2005.12.022genome). The essential cis-acting functions present on the
(vector) genome are localized at both termini of the genomes and
encompass sequences for regeneration of the long terminal
repeats (LTR), DNA integration, transcription, and processing
and termination of mRNAs. In addition, the sequences critical
for genome reverse transcription (primer binding site and poly-
purine tracts, PPT), genome dimerization (dimer linkage site,
DLS), and genome encapsidation (packaging site, Psi) have been
shown to be essential for all retroviral vectors (Buchschacher,
2001).
Members of the Spumaretrovirinae subfamily, for instance,
the simian foamy viruses (SFV), which include the zoonotically
transmitted human isolate HFV/PFVand FFV, are characterized
by significant deviations from the canonical retroviral replica-
tion pathway (Linial, 1999; Rethwilm, 2003). Some of these
distinguishing features of foamy viruses (FV) are (i) the Gag-
independent expression of the Pol precursor protein from a
spliced mRNA (Bodem et al., 1996; Yu et al., 1996), (ii) the Env-
dependent budding (Baldwin and Linial, 1998; Pietschmann et
al., 1999), (iii) the unconventional processing of Gag, Pol, and
Env (Flügel and Pfrepper, 2003; Geiselhart et al., 2004;
Lindemann and Goepfert, 2003), and (iv) the substantial release
of DNA-containing viral particles (Moebes et al., 1997; Roy et
al., 2003; Yu et al., 1996; our unpublished data). All or any of
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elements required in trans and in cis for virus/vector assembly
and release (Mergia and Heinkelein, 2003). This hypothesis is
supported by recent studies on HFV/PFV genome and Pol
polyprotein packaging showing that genomic and a defined
subgenomic RNA are packaged into nascent particles, and that
defined sequences located in the pol-coding region are required
for Pol protein packaging (Peters et al., 2005). These pol
sequences designated CASII (for cis-acting sequence II) had
been previously shown to be required for marker gene transfer in
FV-based vectors. In addition to CASII, CASI located upstream
of and extending into gag has been shown to be essential for Gag
expression and vector function (Heinkelein et al., 1998, 2000,
2002). Since the Psi genome packaging signals of other
retroviruses are located at this site (Buchschacher, 2001), the
PFVCASI may be the functional Psi element also containing the
DLS (Erlwein et al., 1997). Studies using the closely related
SFV-1 also revealed the utilization of bipartite cis-acting
sequences for marker gene transfer (Wu et al., 1998).
Since FVs are promising vectors for gene therapy, an
extended understanding of the cis- and trans-acting elements is
required. While the majority of FV vectors are derived from
HFV/PFV or SFV-1 (Mergia and Heinkelein, 2003), we have
established various replication-competent FFV-derived vectors
for gene transfer and vaccination studies (Schwantes et al.,
2002, 2003). In addition, we have constructed self-inactivating
FFV vectors that, however, resulted in replication-competent
revertants (Bastone and Löchelt, 2004). In order to increase the
safety of these FFV vectors, coding sequences have to be
additionally deleted to prevent generation of replication-
competent revertants.Fig. 1. Schematic presentation of the (A) replication-competent and CMV-IE promote
and Env packaging constructs. The FFV genes, the gfpmarker gene, the LTRs subdiv
boxes. In addition, the major splice donor SD, the RNA dimer linkage sequence DLS
given. The partial U3 deletion in the 3′ LTR compatible with vector replication (Δ) i
promoter are marked by rectangular arrows. Lines below the vector genome indicate
and the leader region LR, between the U5 region and the gag AUG. In panel B, theTo allow construction of safe and efficient FFV-based
vectors, we performed deletion analyses to identify essential
cis-acting FFV sequences. Our results show that a bipartite CAS
is a shared feature of the known FVs. In addition, truncated
Gag- and Pol-derived proteins display trans-dominant negative
but also positive effects on marker gene transfer.
Results
Experimental design
To localize essential cis-acting sequences on the FFV
genome, different deletions in the leader region and in the
gag, pol, and env genes were introduced. As vector backbone
for all deletion constructs, the replication competent vector
pCF-Bet-Gfp was used (Schwantes et al., 2002). In this vector,
protein expression after DNA transfection is mediated by the
strong heterologous CMV-IE promoter and thus independent of
the FFV Tas/Bel 1 transactivator (Fig. 1A). In contrast, vector
and marker gene expression in transduced target cells is directed
by FFV promoters and depends on Tas/Bel 1 (Löchelt, 2003).
By using the FFV-FAB reporter cells for transduction, Tas/Bel 1
expression is employed in this study as a surrogate marker gene
(Zemba et al., 2000).
To determine transduction efficiencies of the deletion
constructs, the vector genomes were cotransfected into 293T
cells with the corresponding trans-expression plasmids sche-
matically shown in Fig. 1B. Two days post-transfection (p.t.),
supernatants were harvested, cleared, and submitted to titration
on FFV-FAB cells. Vector titers determined for the replication
competent vector pCF-Bet-Gfp were set as 100%, and titersr-driven FFV vector pCF-Bet-Gfp (Schwantes et al., 2002) and the (B) Gag, Pol,
ided into U3, R, and U5 regions, and the CMV-IE promoters are marked by open
, the second poly-purine tract PPT, and the Pol and Env splice acceptors SA are
s marked by an angle. The FFV LTR and internal promoter IP and the CMV-IE
the untranslated region UTR, between RNA position 1 and the gag start codon,
heterologous poly-A-addition sites are schematically marked.
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according to this value.
To confirm that the deletions introduced into the vector
genome did not affect the internal promoter (IP)-induced Tas/
Bel 1 expression, all constructs were transfected into FFV-FAB
cells. As determined by light microscopy 2 days, p.t., Tas/Bel 1-
induced β-galactosidase expression levels were comparable for
all constructs used (data not shown).
Localization of essential cis-acting sequences at the 5′-end of
the genome
In order to determine whether essential cis-acting sequences
are located at the 5′-end of the FFV genome, we generatedFig. 2. Schematic outline of the different deletion constructs used and their vector tite
given in the text. (Top) Schematic presentation of the 5′-half of the FFV genome with
of the PCR primers (numbers and arrows) used for the generation of the different dele
(Lower left) Graphic presentation of the deletions introduced into pCF-Bet-Gfp. The
black triangles in the schemes and by X in the corresponding name. Deletions are rep
numbered according to the original positions on the FFV RNA genome. Deletions
deletions affecting pol are named as P. (Lower right) The different deletion construct
293Tcells: mutants pΔLG1 to pΔG3 were cotransfected with pCF-7-Gag, clones pXΔ
pΔP1 and pΔP2 were cotransfected with pBC-FFV-Pol, and mutant pΔPE was cotra
were assayed on FFV-FAB indicator cells and normalized to the parental replication-
Horizontal bars show the median of the normalized construct titer. Error bars enco
efficiency of each vector genome relative to pCF-Bet-Gfp in percent.deletion and insertion constructs solely affecting the leader
region and the gag gene of the replication-competent vector
pCF-Bet-Gfp (Figs. 1A and 2). The deletions introduced were
designed to maintain both, the major splice donor (SD) and the
Pol splice acceptor (SA; Figs. 1A and 2), while the DLS in the
5′ untranslated region (UTR) might have been affected. Vector
constructs were cotransfected into 293T cells together with the
Gag expression plasmid pCF-7-Gag.
As shown in Fig. 2, deletion of the 3′-part of the leader
region plus the gag start codon (pΔLG1, virus genomic RNA
positions 320 to 376) dramatically reduced vector transduction
to about 0.1% in comparison to the parental vector pCF-Bet-
Gfp. These data indicate that the 3′-part of the leader region
between positions 320 and 376 is required for an efficient vectorrs obtained upon cotransfection with the corresponding packaging constructs as
the R and U5 regions, the gag and pol genes, the restriction sites and the position
tion constructs. For additional important genomic features, see legend to Fig. 1A.
insertion of 4 bp into the XhoI site leading to a frame shift in gag is indicated by
resented by dashed lines in the schemes and byΔ in the corresponding name and
spanning the leader region are named as L, those in gag are named as G, and
s were cotransfected with the corresponding trans-complementing constructs in
GP1 to pXΔGP5 were cotransfected with pCF-7-Gag and pBC-FFV-Pol, clones
nsfected with pBC-FFV-Pol and pBC-FFV-Env. Two days p.t., the vector titers
competent vector pCF-Bet-Gfp. Experiments were repeated at least three times.
mpass the standard error of the median, the X axis represents the transduction
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region and the major part of gag (pΔLG2, positions 320 to
1459) showed a less reduced transduction efficiency of about
1%. Insertion of 4 bp into the XhoI site at position 376 resulting
in a frame shift at amino acid (aa) position three of Gag in the
vector clone pX reduced transduction efficiency to less than
0.01%. In contrast, deletions of gag sequences between position
376 and 1142 (Fig. 2, pΔG1, pΔG2) yielded vector
transduction values of more than 30%, whereas deletions up
to position 1459 (pΔG3) still resulted in 6.6% compared to
the parental vector pCF-Bet-Gfp. Thus, almost all N-terminal
and central gag sequences only marginally influence vector
transduction.
These results indicate that the UTR and sequences directly
downstream of the FFV gag AUG are essential for marker gene
transduction by FFV vectors. In analogy to HFV/PFV, we have
designated this cis-acting sequence CASI. Sequences located
downstream of aa three of Gag are not required for efficient
vector transduction.
Mapping of a second essential cis-acting sequence in the pol
gene
To determine whether, similar to the prototypic HFV/PFV
(Heinkelein et al., 1998), a second cis-acting sequence is located
in the pol gene, several deletions were introduced into the 3′-
end of gag and extending into pol (Fig. 2). Vector constructs
with these deletions were cotransfected with Gag and Pol
expression plasmids pCF-7-Gag and pBC-FFV-Pol. Constructs
with pol deletions only were cotransfected with pBC-FFV-Pol,
while the pCF-Bet-Gfp pol and env mutant pΔPE was
cotransfected with Pol and Env expression constructs. Only in
mutant pΔPE, the integrity of the second PPT located in the 3′-
end of pol is affected. All clones were analyzed as described
above.
As shown in Fig. 2, pΔGP1 and pΔGP1B with deletions
ranging from positions 1459 to 3233 or 3373 in gag and pol
showed vector transduction efficiencies of about 0.1% com-
pared to the parental vector. In contrast, vectors pXΔGP1 and
pXΔGP1B both with an additional 4 bp insertion at the 5′-end
of gag and the corresponding gag-pol deletions allowed a 4- to
30-fold higher vector transduction. Deletions extending further
into pol (pXΔGP2, pΔGP2, pXΔGP3, pXΔGP4, and
pXΔGP5) completely abolished vector transduction indicating
the presence of an essential cis-acting element between nt 3373
to 4274. In contrast, the deletion of pol sequences between
position 4024 and 4910 (pΔP1) or 2757 and 4910 (pΔP2) still
allowed marginal vector transduction of less than 0.1%. The
additional deletion construct pΔPE (Fig. 2) which lacked pol
sequences between positions 4910 and 5323 in addition to parts
of env still showed a transduction efficiency of about 10%
compared to the parental vector, indicating that the 3′-end of pol
is not essential for transduction.
In summary, the data indicate that a second essential CAS is
located between positions 3373 and 4910 on the FFV RNA
genome, whereas sequences upstream and downstream of this
stretch are only required for full-level transduction.Analysis of gene expression and particle release from different
deletion constructs
In order to analyze protein expression and processing of the
different deletion constructs in comparison to pCF-Bet-Gfp,
selected vector genomes were cotransfected with the
corresponding trans constructs into 293T cells. Two days p.t.,
cell culture supernatants were harvested for preparation of
vector particles, and the cells were lysed. Cell extracts and
particles were analyzed by immunoblotting using cat #8014
reference serum (Fig. 3).
In cells transfected with the parental replication-competent
vector pCF-Bet-Gfp (wt in panel A, lane 1; panel C, lane 2)
and with deletion clones pXΔGP1 and pΔPE (panel C, lanes 5
and 6), efficient proteolytic processing of p52Gag to p48Gag
was detectable. In contrast, Gag processing was either reduced
in pCF-Bet-Gfp deletion clones pΔG1, pΔG2, pΔG3, and pX
or almost completely suppressed in clones pΔGP1, pΔGP1B,
pΔLG1, and pXΔGP2 requiring long-time exposure of the
immunoblots for detection of p48Gag. Proteolytic processing of
the Pol precursor was strongly reduced in cell lysates from
pCF-Bet-Gfp deletion clones pΔGP1, pΔGP1B, and
pXΔGP2. In extracts from clones pΔGP1 and pΔGP1B
(panel A, lanes 5 and 6), additional bands of about 115 kDa
(Gag-Pol*) were detected, while in clone pΔPE, the C-
terminal truncated Pol precursor (Pol*) was detectable. Minor
bands of 20 to 33 kDa (collectively labeled Gag*) were
present in lysates from cells transfected with clones pΔG2,
pΔG1, pΔLG1, and pX. The asterisks indicate in each case
that these proteins are either truncated Gag and Pol forms or
that they represent aberrant fusions of Gag and Pol protein
sequences (see below).
Immunoblot analyses of released vector particles (Figs.
3B and D) showed considerable release of particles from
cells transfected with the vector genomes pΔG2, pΔG1, and
pΔPE (plus the trans packaging constructs) comparable to
wt pCF-Bet-Gfp-transfected cells. The other vector genomes
directed only minute if any particle release, in general
paralleling the strongly reduced titers of these genomes (Fig.
2) and the compromised proteolytic processing of the cell-
associated Gag protein (Figs. 3A and C). As an exception,
clone pΔPE induced an increased particle release despite the
clearly reduced vector titer compared to the replication
competent pCF-Bet-Gfp vector.
Our data show that the vector titers determined with the
FFV-FAB indicator cells generally correspond to the amount
of particles released into the supernatant. In addition, many
of the deletions introduced into the pCF-Bet-Gfp vector
genome inhibit Gag and Pol polyprotein processing.
Expression of truncated or chimeric proteins from the FFV
vector genomes
To further characterize truncated or aberrant fusion
proteins expressed by the different deletion constructs,
gene expression of the deleted vector genomes was analyzed
2 days p.t. in the absence of any trans construct. Large
Fig. 3. Immunoblot analysis of cell lysates and particles derived from transfected 293T cells. 293T cells were transfected as follows: mutants pΔG2, pΔG3 pΔG1,
pΔLG1, and pX were cotransfected with pCF-7-Gag, vectors pΔGP1, pΔGP1B, pXΔGP2, and pXΔGP1 were cotransfected with pCF-7-Gag and pBC-FFV-Pol, and
mutant pΔPE was cotransfected with pBC-FFV-Pol and pBC-FFV-Env. 2 days p.t., supernatants were harvested for particle preparation, and the cells were lysed.
Cellular extracts (panels A and C) and particles (panels B and D) were analyzed by immunoblotting with serum of FFV-infected cat #8014. The names of the pCF-Bet-
Gfp derived vectors used for transfection are given below the blots. The positions of molecular mass markers are shown in kilodalton at the left hand margin, names of
the detected FFV Gag and Pol proteins and the truncated Gag* forms and internally deleted Gag-Pol* fusion protein are also shown. wt: pCF-Bet-Gfp, mock:
untransfected cells.
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pCF-Bet-Gfp-transfected cells with sera directed against the
N-terminal part of FFV Gag (MA) corresponding to the MA
domain of orthoretroviruses or directed against the central
and C-terminal part of Gag (CA; Figs. 4A and B). For the
gag-pol deletion constructs pΔGP1 and pΔGP1B, truncated
Gag-Pol fusion proteins (marked by an asterisk, see also the
schematic presentation in Fig. 4C) of about 115 kDa in size
were detected with both FFV Gag antisera (for MA see Fig.
4A, lanes 5 and 6; data for CA not shown) or cat serum
#8014 (Fig. 3). Additionally, a shorter truncated Gag-Pol*
fusion protein of about 80 kDa was detected with Gag-
specific sera in cell extracts of construct pΔGP2 (Fig. 4B,
lane 19 and data not shown). Truncated Gag-Pol* fusion
proteins were not seen in the gag-pol deletion constructs
(pXΔGP1, pXΔGP2, pXΔGP3, pXΔGP4, and pXΔGP5)
that contain a frame shift at the 5′-end of gag (Fig. 2). In
addition to the truncated Gag-Pol* fusion proteins, N′-
terminal truncated Gag* proteins of 20 kDa to 33 kDa were
specifically recognized by the CA serum (Figs. 4B and C,
bottom) and cat serum #8014 (Figs. 3A and C and data not
shown) in cell extracts from deletion constructs pX, pΔLG1,
pΔG1, and pΔG2. Since these truncated Gag* proteins were
not detectable with the MA serum specific for the FFV Gag
N-terminus (data not shown), transcription of these shorter
Gag proteins might be initiated at methionine residues
located downstream of the deletions as schematically
depicted in Fig. 4C, bottom.In summary, some of the deleted vector genomes
express N-terminally truncated Gag* or centrally deleted
Gag-Pol* fusion proteins that may affect vector transduc-
tion efficiency.
Influence of truncated Gag o aberrant Gag-Pol* proteins on
vector titers
In order to analyze whether the truncated Gag* and
aberrant Gag-Pol* fusion proteins influence the vector
transduction efficiency, the replication competent vector
pCF-Bet-Gfp was cotransfected with the different deletion
constructs at 1:1 ratios. Two days p.t., titers were determined
using FFV-FAB indicator cells and normalized against the
vector pCF-Bet-Gfp only.
Cotransfection of the deletion construct pΔGP1B (encoding
an artificial Gag-Pol* fusion protein that is incorporated into
released particles) reduced the pCF-Bet-Gfp vector titer
drastically (Fig. 5, black triangle), indicating that the truncated
Gag-Pol* fusion protein expressed from this construct exhibits
trans-dominant negative effects on vector transduction. A
similar yet less pronounced effect is observed for the related
vector pΔGP1. In contrast, cotransfection of vector genomes
pX, pΔGP2, and pΔPE had no effect on the vector titers.
Unexpectedly, cotransfection of deletion constructs pΔLG1,
pΔG1, and pΔG2, all of them expressing N-terminally
truncated Gag* proteins, increased the pCF-Bet-Gfp vector
titer significantly. This indicates that truncated Gag* proteins
Fig. 4. Immunoblot analysis of truncated and fused FFV proteins (marked by asterisks) expressed from different vector genomes and schematic presentation of the
corresponding proteins. 293T cells were transfected with different FFV vector genomes (as given below the blots) without corresponding trans constructs. 2 days p.t.,
cell extracts were harvested and analyzed by immunoblotting with sera against FFV Gag regions corresponding to the MA (A) and CA (B) domains of the
orthoretrovirinae. The positions of molecular mass markers are shown in kilodalton at the right hand margins, the names of the detected FFV Gag and Pol proteins and
the truncated Gag* forms and internally deleted Gag-Pol* fusion protein are shown at the left hand margins. Additional bands seen also in mock-transfected cells were
considered unspecific. Both blots were intentionally overexposed to visualize minor bands. (C) Schematic presentation of the chimeric Gag-Pol* fusion proteins (top)
and the N-terminally truncated FFV Gag* proteins (bottom) expressed by some of the vector genomes. On top, the gag and pol genes plus restriction enzymes sites
used to create the deletions are shown. Dashed lines below indicate the deletions introduced into pCF-Bet-Gfp. Arrows show the fusion proteins and truncated proteins
expressed from the different deletion constructs. Expected molecular masses of the fusion proteins are given in kilodalton. Below, all methionine residues (M) in the
FFV gag gene and the corresponding putative Gag* translation products with their expected molecular masses are shown. The regions against which the MA and CA
serum were directed are indicated by different grey tones.
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vector transduction.
In summary, these data show that expression of truncated
Gag* or artificial Gag-Pol* fusion proteins from the deleted
vector genomes positively or negatively affects vector titers.
Discussion
In this study, we identified and characterized sequence
elements required for efficient FFV vector-mediated Tas/Bel 1
marker gene transfer, in order to develop novel safe FFV-basedreplication-deficient vectors. The simple readout for gene
transfer (Tas/Bel 1-induced gene expression in FFV-FAB target
cells, see below) monitors all steps required for proper
expression and targeting of viral components, their timely and
spatially controlled assembly, packaging of the genomic RNA
and – as special requirements in FVs – the Pol protein, DNA
synthesis in vector particles, and particle budding (Rethwilm,
2003). Subsequently, functional target cell transduction requires
receptor recognition and binding, penetration, uncoating,
completion of provirus DNA synthesis and its targeting to the
sites of DNA integration, integration itself, and onset of Tas/Bel
Fig. 5. Effects of vector genome-expressed truncated FFVGag* and chimeric Gag-Pol* fusion proteins on the titer of the parental vector pCF-Bet-Gfp. 293Tcells were
transfected with pCF-Bet-Gfp and the different deletion constructs at a 1:1 ratio. Two days p.t., vector titers were determined using FFV-FAB cells and normalized with
respect to the vector pCF-Bet-Gfp alone. Experiments were repeated at least three times. Medians of the normalized titers are shown. Error bars represent the standard
error of the median. P values show the result of a paired Student t test between each deletion construct and the parental vector. Deletion constructs whose cotransfection
leads to significant differences in vector titers as compared to pCF-Bet-Gfp alone are depicted as black triangles. Vectors not affecting transduction by the parental
pCF-Bet-Gfp vector in a statistically significant way are depicted as black dots.
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these essential steps directly affects the readout marker gene
transfer. As a consequence, completely different defects may
cause the same final reduction in titer. To further dissect
particular interactions or interferences, one would have to
carefully analyze each parameter which is beyond the scope of
this work. For example, we did not analyze genome and Pol
protein packaging in this study. Thus, we can only infer whether
a given mutation had affected Pol and/or genome packaging. In
addition, we can discuss (see below) our findings in light of
related studies for HFV/PFV (Baldwin and Linial, 1998, 1999;
Erlwein et al., 1997, 1998; Heinkelein et al., 1998, 2000, 2002;
Peters et al., 2005). Interpreting the data of gross sequence
deletion constructs is furthermore complicated by the fact that
the deletions may not only affect essential nucleotide stretches
but may also interfere with proper RNA folding, additional
sequence elements, and the coding capacity of the deleted and
flanking sequences.
In analogy to HFV/PFV and SFV-1 (Heinkelein et al., 1998;
Wu et al., 1998), we have identified two CAS that are, besides
sequences located within and flanking the LTR, required for
marker gene transfer. The position of both CAS is fairly
conserved among FFV and the primate FVs with FFV CASI
starting at least 50 nt upstream of gag and extending into the 5′-
end of gag, whereas CASII of FFV is completely contained
within central and more 3′ terminal parts of pol. In FFV, CASII
does not extend into env, while in HFV/PFV, cis-acting
sequences are also located in env (Heinkelein et al., 1998).
For FFV CASI, sequences around the XhoI restriction site
(directly downstream of the Gag AUG) are particularly sensitive
towards alterations. Duplicating the internal four residues from
5′-CTCGAG-3′ to 5′-CTCGATCGAG-5′ results in the virtual
loss of transduction, whereas the partial or complete deletion ofthese residues in pCF-Bet-Gfp clones pΔLG1 and pΔLG2 still
yields low transduction levels. It therefore appears that
sequences surrounding the XhoI site and their spacing are
especially important. In analogy to other retroviruses, we
assume that FFV CASI contains the DLS upstream of the Gag
start codon together with the major RNA genome encapsidation
signal Psi. Since both elements are characterized by complex
secondary structures, even slight alterations may severely
impair their function, a conclusion supported by data published
for HFV/PFV (Erlwein et al., 1997; Heinkelein et al., 1998).
Since FV Pol packaging has been shown to depend on
genomic RNA encapsidation (Heinkelein et al., 2002; Peters et
al., 2005), there should be at least two packaging/encapsidation
signals on the FFV genome, one for genome packaging (Psi
contained within CASI) and another one that allows interaction
of the Pol polyprotein with genomic RNA (Pol encapsidation
signal, PES). Thus, FFV CASII may facilitate mainly Pol
packaging via RNA–Pol protein interactions, a conclusion
supported by recent data for HFV/PFV (Peters et al., 2005). The
observation that clone pΔPE that lacks the second PPT still
shows significant transduction indicates that this element is not
absolutely required for genome packaging, reverse transcrip-
tion, and/or nuclear import.
In general, significant vector titers are correlated with a
substantial particle release and with Gag and Pol protein
processing in cell extracts and released virus particles (Fig. 3).
In the present study, we focused on effects elicited by
truncated Gag* and artificially fused Gag-Pol* polyproteins
generated by the deletions that had been introduced into the
vector genome. As expected, Gag-Pol* fusion proteins with
deletions in the C terminus of Gag and the N terminus of Pol
(clones pΔGP1 and pΔGP1B) induced significant trans-
dominant negative effects (Figs. 2 and 5). Some of the FFV
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particles (Fig. 3B) similar to the authentic, wt Gag-Pol fusion
proteins expressed by the orthoretroviruses. Preventing expres-
sion of these FFV Gag-Pol* proteins by inducing a frame-shift
at the XhoI site resulted in a partial recovery of the vector titers
(Fig. 2). In cell extracts of clones pΔGP1 and pΔGP1B,
processing of the coexpressed authentic Pol protein was absent
or severely reduced (Figs. 3A and C), indicating that the Gag-
Pol* proteins exhibit a trans-dominant negative effect on wt Pol
in mixed complexes. In contrast, the C-terminal Pol truncation
in clone pΔPE did not exhibit an inhibitory effect on the vector
titer or on Pol processing (Figs. 2 and 3C).
Surprisingly, N-terminally truncated Gag* proteins most
probably generated by translational initiation at internal
methionine residues (Figs. 4B and C, clones pΔLG1, pΔG1,
and pΔG2) appeared to enhance transduction efficiency when
coexpressed together with the intact vector pCF-Bet-Gfp (Fig.
5). In contrast, clone pX that also directs expression of
shortened Gag* proteins did not enhance infectivity. The
enhancing effect of the Gag* proteins may be neutralized by a
trans-dominant negative effect of the CASI XhoI site
duplication, for instance, during wt genome packaging or
dimerization. The enhancing function of Gag* molecules on
FFV vector titers may offer novel ways to increase FV vector
titers and will be investigated in subsequent studies.
The identification and characterization of the FFV CASI and
CASII sequences will allow the construction of FFV-based
replication-deficient vectors with an expanded capacity for the
uptake of heterologous foreign DNA sequences and with
significantly increased biological safety profiles.
Materials and methods
Virus and cells
293T cells and FFV-FAB cells were grown as reported
previously (Zemba et al., 2000). Transfection of plasmid DNA
into 293T cells was performed by calcium coprecipitation
(Wagner et al., 2000). FFV-FAB cells were transfected with
Lipofectamine 2000 according to the manufacturer's instruc-
tions (Invitrogen, Groningen, The Netherlands).
The infectivity of FFV derived replication-competent vectors
and the transduction efficiencies of replication-deficient vectorsTable 1
PCR primers used for construction of FFV Gag and Pol expression plasmids and de
Primer no. in Fig. 2 Used for construct Name Sequence
pCF-7-Gag 2471S 5′-GGGCAAA
2985AS 5′-AAGGTCAC
pBC12-2160S 5′-AGATTAAC
pBC12-2381AS 5′-ACCATCGA
pBC-FFV-Pol 2937S 5′-GCTAAGCT
6417AS 5′-ACATCCCG
1 pXΔGP3 5671S 5′-ATACCCGG
2 pXΔGP4 5778S 5′-ATACCCGG
3 pXΔGP3, pXΔGP4 5980AS 5′-TACTTGGT
a Bold nucleotides are homologous to the FFV sequence. The locations of some o
b Not applicable.were assayed using FFV-FAB cells grown in 24-well plates
(Zemba et al., 2000).
To purify FFV particles, cell culture supernatants from
transfected 293T cells were harvested 2 days p.t., cleared by
low-speed centrifugation, and particles were sedimented
through 2 ml of 20% (wt/vol) sucrose in PBS for 2 h at
28,000 rpm in a SW 41 rotor (Beckman, Munich, Germany) and
resuspended in protein lysis buffer (Wilk et al., 2000).
Molecular cloning
Since FV Gag expression depends on 5′ non-coding
sequences, plasmid pCF-7 (Schwantes et al., 2002) was used
to construct a CMV-IE-driven Gag expression construct, which
contains the FFV R and U5 sequences upstream and a poly-A-
signal downstream of gag. For generation of the Gag expression
plasmid pCF-7-Gag, the gag ORF of pFeFV-7 (Winkler et al.,
1997) was amplified by PCR with primers 2471S and 2985AS
(Table 1) using Pfu DNA polymerase as given by the supplier
(Stratagene, Heidelberg, Germany). By an independent PCR
using pBC12/CMV/IL-2 (Cullen, 1986) as template and
primers pBC12-2160S and pBC12-2381AS, a second PCR
product was generated which had a 3′ overlap with the 5′-end of
the first PCR product. In a subsequent PCR, both amplicons
were combined and amplified with the external primers 2471S
and pBC12-2381AS. Primer pBC12-2381AS contains a
recognition site for ClaI. The vector pCF-7 and the fusion
PCR product were digested with XmaI and ClaI and ligated.
For the FFV Pol expression plasmid pBC-FFV-Pol, the
complete pol ORF was amplified by PCR with primers 2937S
and 6417AS (Table 1). Primer 2937S contains a recognition site
for HindIII and primer 6417AS for XmaI. The vector pBC12/
CMV/IL-2 (Cullen, 1986) was digested with HindIII and XmaI.
The PCR product was digested with the same enzymes, and
both products were ligated, leading to a CMV-IE-driven Pol
expression plasmid.
To determine the localization of essential cis-acting
sequences on the FFV RNA genome, deletions and mutations
(see Fig. 2 for schematic presentation) were introduced into the
replication competent vector pCF-Bet-Gfp (Schwantes et al.,
2002). In construct pΔLG1, sequences between the SwaI site in
the leader region and the XhoI site at the 5′-end of gag (RNA
positions 320 to 376) of clone pCF-Bet-Gfp were deleted. pCF-fined vectors deleted in the Gag-Pol region
Position on FFV RNA
GTATTAGACCTCGG-3′ a 1401
CGGTTAATCTTTACCCCCTTTCTTTCC-3′ 1915
CGGTGACCTTGGCACTGGAGGTG-3′ n.a. b
TGCCGACCCCACTCATGTTC-3′ n.a.
TACCATGGATCTGCTGAAGCCGTT-3′ 1867
GGTCAGGATGAGTCGACTGAAG-3′ 5347
GCGCGCCTCAAACCTCCAAGGCCACAA-3′ 4601
GCGCGCGCTCAGTGGGCAAAGGAAAGG-3′ 4708
GCTGACAACATGAGT-3′ 4910
f the primers are schematically indicated in Fig. 2.
198 P. Bastone et al. / Virology 348 (2006) 190–199Bet-Gfp was digested with SwaI and XhoI, blunt ended with
Klenow enzyme, and the large fragment was religated. In
construct pΔLG2, nucleotides between the SwaI site in the
leader region and the SmaI site in gag (positions 320 to 1459) of
clone pCF-Bet-Gfp were deleted by digestion of pCF-Bet-Gfp
with SwaI and SmaI and religation of the fragments. In construct
pX, 4 bp were introduced in the XhoI site (position 376) at the
5′-end of gag, leading to a frameshift at the extreme end of gag.
For this, pCF-Bet-Gfp was digested with XhoI, blunt ended, and
religated. Constructs pΔG1, pΔG2, and pΔG3 have deletions
in the gag ORF. pCF-Bet-Gfp was digested with XhoI and
correspondingly with Tth111I (pΔG1), Bpu1102I (pΔG2), or
SmaI (pΔG3), blunt ended, and the resulting fragments were
ligated.
Clones pXΔGP1, pΔGP1, pXΔGP1B, pΔGP1B, pXΔGP2,
pΔGP2, pXΔGP3, pXΔGP4, and pXΔGP5 contain deletions
in the 3′ part of the gag and the 5′ and central part of the pol
ORFs. To obtain the 3′ part of these constructs, pCF-Bet-Gfp
was digested with PagI (pXΔGP1, pΔGP1), Alw44I
(pΔGP1B), and AvaI (pXΔGP2, pΔGP2) respectively. There-
after, a second digestion with NheI followed. To obtain the 5′
part of the vector and the plasmid backbone, pCF-Bet-Gfp and
pX, respectively, were digested with NheI and SmaI. The 5′ and
3′ parts were then ligated.
Construct pXΔGP1B was obtained by digestion of pΔGP1B
with XhoI, blunt ending and religation of the DNA. In
constructs pXΔGP3 and pXΔGP4, the nucleotides between
positions 1459 and 4601 or 4708 respectively (spanning the 3′-
end of gag to the central part of pol) were deleted from clone
pX. pX was digested with XmaI and BstZ17I. In a standard
PCR, sense primer 5671S or 5778S and antisense primer
5980AS (Table 1) were used, and pCF-Bet-Gfp served as
template. The sense primers contain a recognition site for XmaI.
The PCR product was digested with XmaI and ligated into the
vector backbone. In the construct pXΔGP5, sequences between
positions 1459 and 4910 were deleted by digestion of construct
pX with SmaI and BstZ17I and religation.
In constructs pΔP1 and pΔP2, parts of the pol ORF were
deleted. For this purpose, pCF-Bet-Gfp was digested with
BstZ17I and XmaI to generate the vector backbone. For the
insert, pCF-Bet-Gfp was digested with BglII (pΔP2) or
Eco91I (pΔP1) and blunt ended. Then the DNA was digested
with XmaI, and the plasmid backbone and the insert were
ligated.
In construct pΔPE that contains a deletion in env (to be
described elsewhere), the 3′-end of pol between positions 4910
and 5232 was additionally deleted. For this purpose, pCF-Bet-
Gfp-ΔE was digested with BstZ17I and SalI, blunt ended, and
religated.
Immuno-blot analyses
Transfected cells were harvested by lysis in 1% SDS.
Immunoblotting of proteins separated on denaturing gels and
detection of specifically bound antibodies by enhanced
chemoluminescence was done as described previously (Winkler
et al., 1997). Cat serum #8014 and both Gag antisera were usedas previously described (Alke et al., 2000; Geiselhart et al.,
2003).
Acknowledgments
We thank Fabian Romen for critically reading the manuscript
and Lutz Gissmann for the continuous support.
References
Alke, A., Schwantes, A., Zemba, M., Flügel, R.M., Löchelt, M., 2000.
Characterization of the humoral immune response and virus replication in
cats experimentally infected with feline foamy virus. Virology 275,
170–176.
Baldwin, D.N., Linial, M.L., 1998. The roles of Pol and Env in the assembly
pathway of human foamy virus. J. Virol. 72, 3658–3665.
Baldwin, D.N., Linial, M.L., 1999. Proteolytic activity, the carboxy terminus of
Gag, and the primer binding site are not required for Pol incorporation into
foamy virus particles. J. Virol. 73, 6387–6393.
Bastone, P., Löchelt, M., 2004. Kinetics and characteristics of replication-
competent revertants derived from self-inactivating foamy virus vectors.
Gene Ther. 11, 465–473.
Bodem, J., Löchelt, M., Winkler, I., Flower, R.P., Delius, H., Flügel, R.M.,
1996. Characterization of the spliced pol transcript of feline foamy virus: the
splice acceptor site of the pol transcript is located in gag of foamy viruses. J.
Virol. 70, 9024–9027.
Buchschacher, G.L., 2001. Introduction to retroviruses and retroviral vectors.
Somat. Cell Mol. Genet. 26, 1–11.
Cullen, B.R., 1986. Trans-activation of human immunodeficiency virus occurs
via a bimodal mechanism. Cell 46, 973–982.
Erlwein, O., Cain, D., Fischer, N., Rethwilm, A., McClure, M.O., 1997.
Identification of sites that act together to direct dimerization of human foamy
virus RNA in vitro. Virology 229, 251–258.
Erlwein, O., Bieniasz, P.D., McClure, M.O., 1998. Sequences in pol are required
for transfer of human foamy virus-based vectors. J. Virol. 72, 5510–5516.
Flügel, R.M., Pfrepper, K.I., 2003. Proteolytic processing of foamy virus Gag
and Pol proteins. Curr. Top. Microbiol. Immunol. 277, 63–88.
Geiselhart, V., Schwantes, A., Bastone, P., Frech, M., Löchelt, M., 2003.
Features of the Env leader protein and the N-terminal Gag domain of feline
foamy virus important for virus morphogenesis. Virology 310, 235–244.
Geiselhart, V., Bastone, P., Kempf, T., Schnölzer, M., Löchelt, M., 2004. Furin-
mediated cleavage of the feline foamy virus Env leader protein. J. Virol. 78,
13573–13581.
Heinkelein, M., Schmidt, M., Fischer, N., Moebes, A., Lindemann, D., Enssle,
J., Rethwilm, A., 1998. Characterization of a cis-acting sequence in the Pol
region required to transfer human foamy virus vectors. J. Virol. 72,
6307–6314.
Heinkelein, M., Thurow, J., Dressler, M., Imrich, H., Neumann-Haefelin, D.,
McClure, M.O., Rethwilm, A., 2000. Complex effects of deletions in the 5′
untranslated region of primate foamy virus on viral gene expression and
RNA packaging. J. Virol. 74, 3141–3148.
Heinkelein, M., Leurs, C., Rammling, M., Peters, K., Hanenberg, H., Rethwilm,
A., 2002. Pregenomic RNA is required for efficient incorporation of pol
polyprotein into foamy virus capsids. J. Virol. 76, 10069–10073.
Lindemann, D., Goepfert, P.A., 2003. The foamy virus envelope glycoproteins.
Curr. Top. Microbiol. Immunol. 277, 111–129.
Linial, M.L., 1999. Foamy viruses are unconventional retroviruses. J. Virol. 73,
1747–1755.
Löchelt, M., 2003. Foamy virus transactivation and gene expression. Curr. Top.
Microbiol. Immunol. 277, 27–61.
Mergia, A., Heinkelein, M., 2003. Foamy virus vectors. Curr. Top. Microbiol.
Immunol. 277, 131–159.
Moebes, A., Enssle, J., Bieniasz, P.D., Heinkelein, M., Lindemann, D., Bock,
M., McClure, M.O., Rethwilm, A., 1997. Human foamy virus reverse
transcription that occurs late in the viral replication cycle. J. Virol. 71,
7305–7311.
199P. Bastone et al. / Virology 348 (2006) 190–199Peters, K., Wiktorowicz, T., Heinkelein, M., Rethwilm, A., 2005. RNA and
protein requirements for incorporation of the Pol protein into foamy virus
particles. J. Virol. 79, 7005–7013.
Pfeifer, A., Verma, I.M., 2001. Viral vectors and their application. In: Knipe,
D.M., Howley, P.M. (Eds.), Virology, vol. 1. Lippincott, Williams and
Wilkins, Philadelphia, pp. 449–469.
Pietschmann, T., Heinkelein, M., Heldmann, M., Zentgraf, H., Rethwilm, A.,
Lindemann, D., 1999. Foamy virus capsids require the cognate envelope
protein for particle export. J. Virol. 73, 2613–2621.
Rethwilm, A., 2003. The replication strategy of foamy viruses. Curr. Top.
Microbiol. Immunol. 277, 1–26.
Roy, J., Rudolph, W., Juretzek, T., Gartner, K., Bock, M., Herchenröder, O.,
Lindemann, D., Heinkelein, M., Rethwilm, A., 2003. Feline foamy virus
genome and replication strategy. J. Virol. 77, 11324–11331.
Schwantes, A., Ortlepp, I., Löchelt, M., 2002. Construction and functional
characterization of feline foamy virus-based retroviral vectors. Virology 301,
53–63.
Schwantes, A., Truyen, U., Weikel, J., Weiss, C., Löchelt, M., 2003. Application
of chimeric feline foamy virus-based retroviral vectors for the induction of
antiviral immunity in cats. J. Virol. 77, 7830–7842.Wagner, A., Doerks, A., Aboud, M., Alonso, A., Tokino, T., Flügel, R.M.,
Löchelt, M., 2000. Induction of cellular genes is mediated by the Bel1
transactivator in foamy virus-infected human cells. J. Virol. 74, 4441–4447.
Wilk, T., de Haas, F., Wagner, A., Rutten, T., Fuller, S., Flügel, R.M., Löchelt,
M., 2000. The intact retroviral Env glycoprotein of human foamy virus is a
trimer. J. Virol. 74, 2885–2887.
Winkler, I., Bodem, J., Haas, L., Zemba, M., Delius, H., Flower, R., Flügel,
R.M., Löchelt, M., 1997. Characterization of the genome of feline foamy
virus and its proteins shows distinct features different from those of
primate spumaviruses. J. Virol. 71, 6727–6741.
Wu, M., Chari, S., Yanchis, T., Mergia, A., 1998. cis-Acting sequences required
for simian foamy virus type 1 vectors. J. Virol. 72, 3451–3454.
Yu, S.F., Baldwin, D.N., Gwynn, S.R., Yendapalli, S., Linial, M.L., 1996.
Human foamy virus replication: a pathway distinct from that of retroviruses
and hepadnaviruses. Science 271, 1579–1582.
Zemba, M., Alke, A., Bodem, J., Winkler, I.G., Flower, R.L., Pfrepper, K.,
Delius, H., Flügel, R.M., Löchelt, M., 2000. Construction of infectious
feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy
virus chimera with serotype-specific Env sequences. Virology 266,
150–156.
